Main Street Financial Solutions’s Novo Nordisk NVO Stock Holding History

Main Street Financial Solutions’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,120	Closed	-$268K	–	544
2024 Q4	$268K	Sell	3,120 -561	-15%	-$60.7K	0.03%	410
2024 Q3	$438K	Buy	3,681 +381	+12%	+$50.8K	0.04%	334
2024 Q2	$471K	Buy	3,300 +611	+23%	+$81K	0.04%	328
2024 Q1	$345K	Sell	2,689 -58	-2%	-$6.9K	0.04%	386
2023 Q4	$284K	Buy	2,747 +14	+0.5%	+$1.38K	0.04%	371
2023 Q3	$249K	Buy	2,733 +153	+6%	+$13.5K	0.04%	383
2023 Q2	$209K	Buy	+2,580	New	+$211K	0.03%	419

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Main Street Financial Solutions's NVO Position: Q1 2025 in Review

Main Street Financial Solutions sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 3,120 shares — an estimated $268K sold.

Main Street Financial Solutions first reported a position in NVO in Q2 2023 and held it in 7 quarters. The position peaked at $471K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

Main Street Financial Solutions reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
Main Street Financial Solutions sold 3,120 Novo Nordisk shares in Q1 2025, an estimated $268K.
Main Street Financial Solutions first reported a position in Novo Nordisk in Q2 2023 and held it in 7 quarters.
Main Street Financial Solutions's Novo Nordisk position peaked at $471K in Q2 2024.
1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Main Street Financial Solutions's 13F filing for Q1 2025, filed 8 May 2025.